Free Trial
OTCMKTS:PCYN

Procyon (PCYN) Stock Price, News & Analysis

$0.18 0.00 (0.00%)
As of 04/17/2025

About Procyon Stock (OTCMKTS:PCYN)

Key Stats

Today's Range
$0.18
$0.18
50-Day Range
$0.18
$0.18
52-Week Range
$0.17
$0.34
Volume
N/A
Average Volume
11,100 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Procyon Corporation, together with its subsidiaries, develops and markets proprietary medical products for use in the treatment of pressure ulcers, stasis ulcers, wounds, dermatitis, inflammation, and other skin problems in the United States. It provides advanced skin and wound care products, including the hydrogel wound dressing products, post op surgical kits, saline wound washes, care lotions, and barrier lotions to promote healing in wound and problematic skin conditions, as well as hand sanitizer under the AMERIGEL brand name. The company also offers Advantagen, a surgical collagen powder that promotes wound closure and reduces the potential for surgical site infection; and rolled gauze wound care kits. In addition, it provides Bioactive Collagen products in the form of power and matrix under the HELIX3 brand name. Further, the company offers wound care products, such as calcium alginate, foam, gauze, and hyrdocolloid dressing products, as well as retention tapes; and wound care kits, which include calcium alginate, collagen matrix, collagen powder, foam, and hydrogel wound care kits under the AMERX brand name, as well as compression garment line products under the EXTREMIT-EASE brand name. It sells its products through distributors to institutional customers, such as hospitals, wound care clinics, nursing homes, home health agencies, physicians, and health care practitioners; and retail customers through direct sales, and internet sales, as well as through independent and retail chain drug stores. Procyon Corporation was incorporated in 1987 and is based in Oldsmar, Florida.

Receive PCYN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Procyon and its competitors with MarketBeat's FREE daily newsletter.

PCYN Stock News Headlines

TTHG Titanium Holdings Group, Inc.
[Action Required] Claim Your FREE IRS Loophole Guide
This shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the biggest "dollar reset" since 1971.
Procyon Corporation (PCYN)
Procyon Corp. - New (PCYN)
Procyon Corp.
See More Headlines

PCYN Stock Analysis - Frequently Asked Questions

Procyon's stock was trading at $0.2380 at the beginning of the year. Since then, PCYN stock has decreased by 24.4% and is now trading at $0.18.
View the best growth stocks for 2025 here
.

Shares of PCYN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Procyon investors own include Curaleaf (CURLF), California Republic Bancorp (CRPB), Aphria (APHA), Aerie Pharmaceuticals (AERI), McEwen Mining (MUX), Discovery Silver (DSV) and Digital Ally (DGLY).

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:PCYN
Fax
N/A
Employees
20
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (OTCMKTS:PCYN) was last updated on 4/19/2025 by MarketBeat.com Staff
From Our Partners